首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.
【2h】

Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.

机译:血小板和α1-蛋白酶抑制剂对因子XIa活性的调节。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have studied the complex interrelationships between platelets, Factor XIa, alpha 1-protease inhibitor and Factor IX activation. Platelets were shown to secrete an inhibitor of Factor XIa, and to protect Factor XIa from inactivation in the presence of alpha 1-protease inhibitor and the secreted platelet inhibitor. This protection of Factor XIa did not arise from the binding of Factor XIa to platelets, the presence of high molecular weight kininogen, or the inactivation of alpha 1-protease inhibitor by platelets. The formation of a complex between alpha 1-protease inhibitor and the active-site-containing light chain of Factor XIa was inhibited by activated platelets and by platelet releasates, but not by high molecular weight kininogen. These results support the hypothesis that platelets can regulate Factor XIa-catalyzed Factor IX activation by secreting an inhibitor of Factor XIa that may act primarily outside the platelet microenvironment and by protecting Factor XIa from inhibition, thereby localizing Factor IX activation to the platelet plug.
机译:我们已经研究了血小板,因子XIa,α1-蛋白酶抑制剂和因子IX激活之间的复杂相互关系。已显示血小板分泌因子XIa抑制剂,并在存在α1-蛋白酶抑制剂和分泌的血小板抑制剂的情况下保护因子XIa免受灭活。因子XIa的这种保护不是由于因子XIa与血小板的结合,高分子量激肽原的存在或血小板对α1-蛋白酶抑制剂的灭活而引起的。活化的血小板和血小板释放物抑制了α1-蛋白酶抑制剂与因子XIa含活性位点的轻链之间的复合物的形成,但高分子量激肽原却没有抑制这种复合物的形成。这些结果支持以下假设:血小板可以通过分泌可能主要在血小板微环境外起作用的因子XIa抑制剂并通过保护因子XIa不受抑制,从而将因子IX激活定位于血小板栓上来调节因子XIa催化的因子IX激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号